tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Instil Bio reports Q3 EPS ($1.75) vs ($2.55) last year
PremiumThe FlyInstil Bio reports Q3 EPS ($1.75) vs ($2.55) last year
2M ago
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment
Premium
Company Announcements
Instil Bio’s AXN-2510 Study: A Promising Step in Cancer Treatment
3M ago
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
3M ago
Instil Bio Reports Promising Phase 2 Study Results
PremiumCompany AnnouncementsInstil Bio Reports Promising Phase 2 Study Results
6M ago
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
Premium
The Fly
Instil Bio: ImmuneOnco reports results from Phase 2 study of IMM2510/AXN-2510
6M ago
Instil Bio announces FDA clearance of IND application for AXN-2510
Premium
The Fly
Instil Bio announces FDA clearance of IND application for AXN-2510
7M ago
Instil Bio Advances Phase 2 Trial in China
PremiumCompany AnnouncementsInstil Bio Advances Phase 2 Trial in China
8M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100